172 related articles for article (PubMed ID: 7927768)
1. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.
Tzianabos AO; Onderdonk AB; Zaleznik DF; Smith RS; Kasper DL
Infect Immun; 1994 Nov; 62(11):4881-6. PubMed ID: 7927768
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
[TBL] [Abstract][Full Text] [Related]
3. Bacterial structure and functional relation to abscess formation.
Tzianabos AO; Onderdonk AB; Kasper DL
Infect Agents Dis; 1994 Oct; 3(5):256-65. PubMed ID: 7866658
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.
Tzianabos AO; Kasper DL; Onderdonk AB
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S132-40. PubMed ID: 7548535
[TBL] [Abstract][Full Text] [Related]
5. Structural features of polysaccharides that induce intra-abdominal abscesses.
Tzianabos AO; Onderdonk AB; Rosner B; Cisneros RL; Kasper DL
Science; 1993 Oct; 262(5132):416-9. PubMed ID: 8211161
[TBL] [Abstract][Full Text] [Related]
6. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
[TBL] [Abstract][Full Text] [Related]
7. IL-2 mediates protection against abscess formation in an experimental model of sepsis.
Tzianabos AO; Russell PR; Onderdonk AB; Gibson FC; Cywes C; Chan M; Finberg RW; Kasper DL
J Immunol; 1999 Jul; 163(2):893-7. PubMed ID: 10395684
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.
Kalka-Moll WM; Wang Y; Comstock LE; Gonzalez SE; Tzianabos AO; Kasper DL
Infect Immun; 2001 Apr; 69(4):2339-44. PubMed ID: 11254591
[TBL] [Abstract][Full Text] [Related]
9. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
[TBL] [Abstract][Full Text] [Related]
10. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.
Tzianabos AO; Wang JY; Lee JC
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9365-70. PubMed ID: 11470905
[TBL] [Abstract][Full Text] [Related]
11. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationships for polysaccharide-induced intra-abdominal abscesses.
Tzianabos AO; Onderdonk AB; Smith RS; Kasper DL
Infect Immun; 1994 Aug; 62(8):3590-3. PubMed ID: 8039936
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
[TBL] [Abstract][Full Text] [Related]
15. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria.
Tzianabos AO; Finberg RW; Wang Y; Chan M; Onderdonk AB; Jennings HJ; Kasper DL
J Biol Chem; 2000 Mar; 275(10):6733-40. PubMed ID: 10702228
[TBL] [Abstract][Full Text] [Related]
16. Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation.
Stingele F; Corthésy B; Kusy N; Porcelli SA; Kasper DL; Tzianabos AO
J Immunol; 2004 Feb; 172(3):1483-90. PubMed ID: 14734725
[TBL] [Abstract][Full Text] [Related]
17. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis.
Coyne MJ; Tzianabos AO; Mallory BC; Carey VJ; Kasper DL; Comstock LE
Infect Immun; 2001 Jul; 69(7):4342-50. PubMed ID: 11401972
[TBL] [Abstract][Full Text] [Related]
19. Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci.
Coyne MJ; Kalka-Moll W; Tzianabos AO; Kasper DL; Comstock LE
Infect Immun; 2000 Nov; 68(11):6176-81. PubMed ID: 11035722
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
